{"schema_version":"secwatch.filing_event.v1","accession":"0001723128-22-000012","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.005818+00:00","generated_at":"2026-06-26T00:49:42.054814+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Amneal reports Q1 2022 net revenue $498M (+1% YoY), GAAP net loss $2M, adj. EPS $0.12","bullets":["Net revenue $498M vs $493M in Q1 2021; driven by generics and AvKARE distribution, partially offset by Zomig loss of exclusivity.","GAAP net loss $2M ($0.01 diluted loss per share) vs net income $7M in Q1 2021.","Adjusted EBITDA $100M including $5M R&D milestone expense; adjusted diluted EPS $0.12.","Company maintains 2022 full-year outlook; highlights FDA approvals for two biosimilars and Saol Baclofen acquisition.","Growth strategy focused on biosimilars, injectables, and advancing R&D pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001723128-22-000012","json":"https://secwatch.observer/filing/0001723128-22-000012.json","markdown":"https://secwatch.observer/filing/0001723128-22-000012.md","text":"https://secwatch.observer/filing/0001723128-22-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000172312822000012/0001723128-22-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000172312822000012/amrx-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:49:42.054814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}